<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337699</url>
  </required_header>
  <id_info>
    <org_study_id>25-SMI-2014</org_study_id>
    <nct_id>NCT02337699</nct_id>
  </id_info>
  <brief_title>Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain</brief_title>
  <acronym>GASPA</acronym>
  <official_title>DORSAL ROOT GANGLION STIMULATION AS TREATMENT FOR POSTSURGICAL GROIN PAIN (GASPA Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      25-SMI-2014 is a post market observational, questionnaire based study to assess the&#xD;
      effectiveness of the Axium neurostimulator as a treatment for chronic post surgical groin&#xD;
      pain. Within is also a nested feasibility study to assess the clinical utility of a&#xD;
      Quantitive Sensory Testing (QST) protocol in the management of the described study group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The Principal investigator retired without replacement. Only one patient was enrolled and&#xD;
    completed the entire study without adverse events.&#xD;
  </why_stopped>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Main Study: Pain Relief - Assessed be Change in Pain Intensity from Pre-Treatment Baseline</measure>
    <time_frame>Post implantation at; 1, 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility Study: To determine subject acceptance of the described QST methodology and protocol; assessed using a 5 point Likert scale</measure>
    <time_frame>Baseline then Post implantation at; 1, 3 and 6 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1</enrollment>
  <condition>Post Surgical Groin Pain</condition>
  <arm_group>
    <arm_group_label>Treated Subjects</arm_group_label>
    <description>All subjects recruited into the main study treated with the Axium neurostimulator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QST Group</arm_group_label>
    <description>A sub-set of the main study group who also consent to take part in the Quantitative Sensory Testing based feasibility study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation with the commercially available Axium neurostimulator</intervention_name>
    <arm_group_label>QST Group</arm_group_label>
    <arm_group_label>Treated Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>QST Testing</intervention_name>
    <arm_group_label>QST Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Post Surgical Groin Pain Patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Main Study&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Male&#xD;
&#xD;
          2. Age between &gt;18 and &lt;65 years&#xD;
&#xD;
          3. Unilateral post surgical groin pain for &gt;6 months&#xD;
&#xD;
          4. Pain localized to the region defined by the anterior superior iliac spine (ASIS), the&#xD;
             pubic tubercle, and the groin-gluteal-greater trochanter triangles (3G) point,&#xD;
&#xD;
          5. Pain has no surgical indication&#xD;
&#xD;
          6. Subjects meet the criteria for SCS implantation as set out in the Dutch&#xD;
             Neuromodulation Society Guideline&#xD;
&#xD;
          7. Pain characterized by neuropathy and/or allodynia&#xD;
&#xD;
          8. Average daily baseline pain intensity baseline VAS greater than or equal to 50 mm on a&#xD;
             100mm VAS scale&#xD;
&#xD;
          9. Patient willing and able to give informed consent and to participate in observational&#xD;
             study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to speak/read Dutch&#xD;
&#xD;
          2. Bilateral and/or recurrent hernia.&#xD;
&#xD;
          3. Radiofrequency or injection therapy at or close to a target DRG in the 90 days prior&#xD;
             to enrolment&#xD;
&#xD;
          4. Current illicit drug use and/or alcohol dependence&#xD;
&#xD;
          5. Active infection, or conditions or indwelling devices that pose an increased risk of&#xD;
             infection&#xD;
&#xD;
          6. Active implantable device including implantable cardiac defibrillator, pacemaker,&#xD;
             spinal cord stimulator or intrathecal drug pump&#xD;
&#xD;
          7. Participation in another clinical study during the study period.&#xD;
&#xD;
          8. Any other disorder, condition, or circumstance that, in the opinion of the principal&#xD;
             investigator, represents a risk to successful completion of all study activities.&#xD;
&#xD;
        Additional Criteria for nested feasibility study&#xD;
&#xD;
        Additional Inclusion Criteria&#xD;
&#xD;
          1. Participation in the observational study&#xD;
&#xD;
          2. Sign off for sub-study on patient informed consent&#xD;
&#xD;
        Additional Exclusion Criteria&#xD;
&#xD;
        1. For sub-study participation only: pain conditions [aside from the post surgical groin&#xD;
        pain to be treated], extensive scar tissue, skin conditions, or sensorimotor abnormalities&#xD;
        in the areas for QST assessments: the painful groin, the contralateral groin, the&#xD;
        ipsilateral arm, and the contralateral hand&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 9, 2015</study_first_submitted>
  <study_first_submitted_qc>January 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2015</study_first_posted>
  <last_update_submitted>January 31, 2019</last_update_submitted>
  <last_update_submitted_qc>January 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

